ipscell.com
Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million - The Niche
Advanced Cell Technology (ACT; stock symbol ACTC) announced that it has secured $35 million in funding, which is great news
Professor Paul Knoepfler, Ph.D.
